Cargando…
CHIME - A tailored HCV microelimination project in Viennese people who inject drugs at drug centralized substitution centers
BACKGROUND: Hepatitis C remains highly prevalent among people who inject drugs (PWIDs). We propose an integrated approach for screening/diagnostic testing and treatment in 6,665 Viennese PWIDs registered to access opioid agonist therapy (OAT). METHODS: OAT prescriptions were required monthly at one...
Autores principales: | Schwarz, Caroline, Schubert, Raphael, Schwarz, Michael, Schütz, Angelika, Jenke, Anika, Bauer, David, Steinwender, Benjamin, Gutic, Enisa, Reiberger, Thomas, Haltmayer, Hans, Gschwantler, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474458/ https://www.ncbi.nlm.nih.gov/pubmed/37663576 http://dx.doi.org/10.1016/j.jve.2023.100338 |
Ejemplares similares
-
Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy
por: Schwarz, M., et al.
Publicado: (2023) -
Directly observed therapy for HCV with glecaprevir/pibrentasvir alongside opioid substitution in people who inject drugs—First real world data from Austria
por: Schmidbauer, Caroline, et al.
Publicado: (2020) -
Directly observed therapy at opioid substitution facilities using sofosbuvir/velpatasvir results in excellent SVR12 rates in PWIDs at high risk for non-adherence to DAA therapy
por: Schmidbauer, Caroline, et al.
Publicado: (2021) -
The ‘Viennese epidemic’ of acute HCV in the era of direct‐acting antivirals
por: Chromy, David, et al.
Publicado: (2022) -
Epidemiological trends in HCV transmission and prevalence in the Viennese HIV+ population
por: Schmidbauer, Caroline, et al.
Publicado: (2020)